Related references
Note: Only part of the references are listed.A Novel Neutralization Antibody Assay Method to Overcome Drug Interference with Better Compatibility with Acid-Sensitive Neutralizing Antibodies
Dilki Wickramarachchi et al.
AAPS JOURNAL (2023)
Direct bioanalysis or indirect calculation of target engagement and free drug exposure: do we apply double standards?
Gregor Jordan et al.
BIOANALYSIS (2023)
SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
Alison Tarke et al.
CELL (2022)
Dose-dependent inactivation of airway tryptase with a novel dissociating anti-tryptase antibody (MTPS9579A) in healthy participants: A randomized trial
Sharon M. Rymut et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2022)
Quick identification of target antigens by tissue flow cytometry for CAR-T therapy in B-cell malignancies
Xinjian Yu et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2022)
Comparison of three parallelism assessment methods of biomarker quantification by LC-MS/MS: a case study of the bioanalysis of creatinine in human urine samples
Xiazi Qiu et al.
BIOANALYSIS (2022)
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness (Part 3-Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization)
Lina Loo et al.
BIOANALYSIS (2022)
2021 White Paper on Recent Issues in Bioanalysis: ISR for Biomarkers, Liquid Biopsies, Spectral Cytometry, Inhalation/Oral & Multispecific Biotherapeutics, Accuracy/LLOQ for Flow Cytometry (Part 2-Recommendations on Biomarkers/CDx Assays Development & Validation, Cytometry Validation & Innovation, Biotherapeutics PK LBA Regulated Bioanalysis, Critical Reagents & Positive Controls Generation)
Sarah Hersey et al.
BIOANALYSIS (2022)
2021 White Paper on Recent Issues in Bioanalysis: Mass Spec of Proteins, Extracellular Vesicles, CRISPR, Chiral Assays, Oligos; Nanomedicines Bioanalysis; ICH M10 Section 7.1; Non-Liquid & Rare Matrices; Regulatory Inputs (Part 1A-Recommendations on Endogenous Compounds, Small Molecules, Complex Methods, Regulated Mass Spec of Large Molecules, Small Molecule, PoC & Part 1B-Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine)
Surinder Kaur et al.
BIOANALYSIS (2022)
Criteria of slope and endogenous level for selection of matrix in the quantitation of endogenous compounds by LC-MS/MS
Allena Ji Ji et al.
BIOANALYSIS (2022)
Neutralization Activity of Anti-drug Antibodies Against a Biotherapeutic Can Be Predicted from a Comprehensive Pharmacokinetics, Pharmacodynamics, and Anti-drug Antibody Data Analysis
Weifeng Xu et al.
AAPS JOURNAL (2022)
Preclinical Observations of Systemic and Ocular Antidrug Antibody Response to Intravitreally Administered Drugs
Uwe Wessels et al.
AAPS JOURNAL (2022)
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses (vol 586, pg 594, 2020)
Ugur Sahin et al.
NATURE (2021)
2020 White Paper on Recent Issues in Bioanalysis: BMV of Hybrid Assays, Acoustic MS, HRMS, Data Integrity, Endogenous Compounds, Microsampling and Microbiome (Part 1-Recommendations on Industry/Regulators Consensus on BMV of Biotherapeutics by LCMS, Advanced Application in Hybrid Assays, Regulatory Challenges in Mass Spec, Innovation in Small Molecules, Peptides and Oligos)
Hendrik Neubert et al.
BIOANALYSIS (2021)
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
Anthony T. Tan et al.
CELL REPORTS (2021)
High-Content Screening for the Detection of Drug-Induced Oxidative Stress in Liver Cells
Maria Teresa Donato et al.
ANTIOXIDANTS (2021)
2020 White Paper on Recent Issues in Bioanalysis: BAV Guidance, CLSI H62, Biotherapeutics Stability, Parallelism Testing, CyTOF and Regulatory Feedback (Part 2A-Recommendations on Biotherapeutics Stability, PK LBA Regulated Bioanalysis, Biomarkers Assays, Cytometry Validation & Innovation Part 2B-Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine)
Susan Spitz et al.
BIOANALYSIS (2021)
2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation (Part 3-Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene & Cell Therapy and Vaccine Assays)
Bart Corsaro et al.
BIOANALYSIS (2021)
Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice
Marina Villanueva-Paz et al.
ANTIOXIDANTS (2021)
The impact of ligand binding based assays critical reagent characterization and storage
Jonathan Haulenbeek et al.
BIOANALYSIS (2021)
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
Ane Ogbe et al.
NATURE COMMUNICATIONS (2021)
A survey of pharmacokinetic bioanalytical methods in biosimilar biological license applications for the assessment of target and antidrug antibody effects
Dana T. Hackel et al.
BIOANALYSIS (2021)
A survey of pharmacokinetic bioanalytical methods in biosimilar biological license applications for the assessment of target and antidrug antibody effects
Dana T. Hackel et al.
BIOANALYSIS (2021)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Ugur Sahin et al.
NATURE (2020)
Development and evaluation of an ultrasensitive free VEGF-A immunoassay for analysis of human aqueous humor
Jens C. Goepfert et al.
BIOANALYSIS (2019)
Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients
Daniel Margerie et al.
BMC MEDICAL GENOMICS (2019)
2019 White Paper on Recent Issues in Bioanalysis: Chromatographic Assays (Part 1-Innovation in Small Molecules and Oligonucleotides & Mass Spectrometric Method Development Strategies for Large Molecule Bioanalysis)
Christine Fandozzi et al.
BIOANALYSIS (2019)
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
Karolina Woroniecka et al.
CLINICAL CANCER RESEARCH (2018)
Immunogenicity testing of therapeutic antibodies in ocular fluids after intravitreal injection
Uwe Wessels et al.
BIOANALYSIS (2018)
Development and validation of a functional cell-based neutralizing antibody assay for ipilimumab
Weifeng Xu et al.
BIOANALYSIS (2018)
2018 White Paper on Recent Issues in Bioanalysis: 'A global bioanalytical community perspective on last decade of incurred samples reanalysis (ISR)' (Part 1-small molecule regulated bioanalysis, small molecule biomarkers, peptides & oligonucleotide bioanalysis)
Jan Welink et al.
BIOANALYSIS (2018)
2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3-LBA/cell-based assays: immunogenicity, biomarkers and PK assays)
Lauren Stevenson et al.
BIOANALYSIS (2018)
2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3-LBA: immunogenicity, biomarkers and PK assays)
Shalini Gupta et al.
BIOANALYSIS (2017)
The Decennial Index of the White Papers in Bioanalysis: 'A Decade of Recommendations (2007-2016)'
Wei Garofolo et al.
BIOANALYSIS (2017)
Overcoming disease-specific matrix effect in a clinical pharmacokinetic assay using a microfluidic immunoassay technology
Kathi Williams et al.
BIOANALYSIS (2017)
Evaluation of the potential use of hybrid LC-MS/MS for active drug quantification applying the 'free analyte QC concept'
Gregor Jordan et al.
BIOANALYSIS (2017)
2017 White Paper: rise of hybrid LBA/LCMS immunogenicity assays (Part 2: hybrid LBA/LCMS biotherapeutics, biomarkers & immunogenicity assays and regulatory agencies' inputs)
Hendrik Neubert et al.
BIOANALYSIS (2017)
3-(4-Hydroxyphenyl)propionic acid: the forgotten detection substrate for ligand-binding assay-based bioanalysis
Gregor Jordan et al.
BIOANALYSIS (2017)
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1-LCMS: small molecules, peptides and small molecule biomarkers)
Jan Welink et al.
BIOANALYSIS (2017)
Optimizing recovery of frozen human peripheral blood mononuclear cells for flow cytometry
Bo Langhoff Honge et al.
PLOS ONE (2017)
Validation of a ligand-binding assay for active protein drug quantification following the 'free analyte QC concept'
Eginhard Schick et al.
BIOANALYSIS (2016)
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3-LBA, biomarkers and immunogenicity)
Susan Richards et al.
BIOANALYSIS (2016)
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1-small molecules, peptides and small molecule biomarkers by LCMS)
Eric Yang et al.
BIOANALYSIS (2016)
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 2-Hybrid LBA/LCMS and input from regulatory agencies)
An Song et al.
BIOANALYSIS (2016)
Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes
Patrick H. Lizotte et al.
JCI INSIGHT (2016)
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 2-hybrid LBA/LCMS and input from regulatory agencies)
Brad Ackermann et al.
BIOANALYSIS (2015)
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 1-small molecules by LCMS)
Jan Welink et al.
BIOANALYSIS (2015)
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3-LBA, biomarkers and immunogenicity)
Lakshmi Amaravadi et al.
BIOANALYSIS (2015)
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 1-small molecules by LCMS)
Eric Fluhler et al.
BIOANALYSIS (2014)
Free analyte QC concept: a novel approach to prove correct quantification of free therapeutic protein drug/biomarker concentrations
Roland F. Staack et al.
BIOANALYSIS (2014)
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 2-hybrid LBA/LCMS, ELN & regulatory agencies' input)
Dawn Dufield et al.
BIOANALYSIS (2014)
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3-LBA and immunogenicity)
Lauren Stevenson et al.
BIOANALYSIS (2014)
2013 White Paper on recent issues in bioanalysis: 'hybrid' - the best of LBA and LCMS
Lauren Stevenson et al.
BIOANALYSIS (2013)
2012 White Paper on Recent Issues in Bioanalysis and Alignment of Multiple Guidelines
Binodh DeSilva et al.
BIOANALYSIS (2012)
Mathematical simulations for bioanalytical assay development: the (un-)necessity and (im-)possibility of free drug quantification
Roland F. Staack et al.
BIOANALYSIS (2012)
Bioanalytical Approaches to Quantify Total and Free Therapeutic Antibodies and Their Targets: Technical Challenges and PK/PD Applications Over the Course of Drug Development
Jean W. Lee et al.
AAPS JOURNAL (2011)
2011 White Paper on Recent Issues in Bioanalysis and Regulatory Findings from Audits and Inspections
Fabio Garofolo et al.
BIOANALYSIS (2011)
Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs
J. Cummings et al.
BRITISH JOURNAL OF CANCER (2010)
2010 White Paper on Recent Issues in Regulated Bioanalysis & Global Harmonization of Bioanalytical Guidance
Natasha Savoie et al.
BIOANALYSIS (2010)
2009 White Paper on Recent Issues in Regulated Bioanalysis from The 3rd Calibration and Validation Group Workshop
Natasha Savoie et al.
BIOANALYSIS (2010)
The 2nd Calibration and Validation Group Workshop on recent issues in Good Laboratory Practice bioanalysis
Natasha Savoie et al.
BIOANALYSIS (2009)
Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials
Marta Bull et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in ad5 HIV type 1 gag vaccinated human subjects
Timothy W. Tobery et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2006)
Detection of neutralizing anti-therapeutic protein antibodies in serum or plasma samples containing high levels of the therapeutic protein
JA Lofgren et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
Effects of cryopreservation on lymphocyte immunophenotype and function
A Costantini et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Preservation of lymphocyte immunophenotype and proliferative responses in cryopreserved peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected donors: Implications for multicenter clinical trials
KA Reimann et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2000)
Share Paper
